This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Background: There are limited studies on wall imaging of human basilar artery (BA). Our aim was to investigate remodeling mode of advanced BA atherosclerosis using 3-T MRI.
Methods: Thirty-two consecutive symptomatic patients with atherosclerotic BA stenosis ≥70% were imaged with a 3-T magnetic resonance scanner. Proton density-weighted (PDW) cross-sectional images with submillimeter voxel size were obtained. The vessel area (VA) and lumen area (LA) at the maximal lumen narrowing (MLN) site and reference site were measured. Intraobserver and interobserver variability was determined by intraclass correlation coefficient (ICC). Wall area (WA) was estimated by VA − LA. Plaque size (PS) was estimated by WA at MLN site − reference WA. Percent plaque burden was calculated as (PS/VA at MLN site) × 100%. Remodeling index (RI) was the ratio of VA at MLN site to reference VA. RI ≥1.05 was defined as positive remodeling (PR) and RI <1.05 as non-PR.
Results: Measurements of cross-sectional BA images were available in 30 of 32 patients. Intraobserver or interobserver variability was small, with ICC ranging from 0.955 to 0.996. The mean RI of the 30 patients was 1.2 ± 0.4. PR was found in 19 (63.3%) patients and non-PR in 11 (36.7%) patients. Compared with the non-PR group, the PR group had greater PS (15.0 ± 9.3 mm2 vs 6.4 ± 3.9 mm2, p = 0.007) and greater percent plaque burden (50.5 ± 9.9% vs 28.5 ± 12.7%, p < 0.0001).
Conclusions: 3-T high-resolution PDW imaging is a reproducible tool for measuring BA dimensions. In patients with advanced BA atherosclerosis, PR lesions are more frequently observed and contain larger plaques than non-PR lesions.
Footnotes
-
Study funding: Supported by the National Natural Science Foundation of China and by the PLA 11.5th Medical Foundation.
Disclosure: Author disclosures are provided at the end of the article.
Received October 22, 2009. Accepted in final form March 9, 2010.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Rituximab Therapy in the Treatment of Juvenile Myasthenia Gravis: The French Experience
Dr. Henry J. Kaminski and Dr. Sarah Wright
► Watch
Topics Discussed
Alert Me
Recommended articles
Non-moyamoya vessel network formation along steno-occlusive middle cerebral artery
Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis
Nonstenotic carotid plaque on CT angiography in patients with cryptogenic stroke
The Warfarin-Aspirin Symptomatic Intracranial Disease Study